Evidence map›Paper›PMID 31989252›Full record

ArticleJournal of gastroenterology2020

A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn's disease.

Shigeki Bamba, Ryosuke Sakemi, Toshimitsu Fujii, Teruyuki Takeda, Shin Fujioka, Kento Takenaka, Hiroki Kitamoto, Shotaro Umezawa, Hirotake Sakuraba, Toshihiro Inokuchi and 26 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 1 country.

Shigeki BambaDivision of Clinical Nutrition, Shiga University of Medical Science, Seta-Tsukinowa, Otsu, 520-2192, Japan. sb@belle.shiga-med.ac.jp.ORCID http://orcid.org/0000-0002-4108-5894
Ryosuke SakemiDepartment of Gastroenterology, Tobata Kyoritsu Hospital, Kitakyusyu, Japan.
Toshimitsu FujiiDepartment of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Teruyuki TakedaDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.
Shin FujiokaDepartment of Medicine and Clinical Science, Kyushu University Graduate Schools of Medical Science, Fukuoka, Japan.
Kento TakenakaDepartment of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Hiroki KitamotoDepartment of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shotaro UmezawaCenter for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital, Kamakura, Japan.
Hirotake SakurabaDepartment of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Toshihiro InokuchiDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Okayama, Japan.
Norimasa FukataThird Department of Internal Medicine, Kansai Medical University, Hirakata, Japan.
Shinta MizunoDivision of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo, Japan.
Masaki YamashitaDivision of Gastroenterology and Hepatology, Saint Marianna University School of Medicine, Kawasaki, Japan.
Shinichiro ShinzakiDepartment of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Hiroki TanakaIBD Center, Sapporo Kosei General Hospital, Sapporo, Japan.
Hidetoshi TakedatsuDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Ryo OzakiCenter for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Kei MoriyaDepartment of Gastroenterology and Hepatology, Nara Medical University School of Medicine, Kashihara, Japan.
Manabu IshiiDivision of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan.
Tetsu KinjoDepartment of Endoscopy, University of Ryukyus Hospital, Nishihara, Japan.
Keiji OzekiDepartment of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Makoto OoiDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Ryohei HayashiDepartment of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Kazuki Kakimoto2nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan.
Yuichi ShimodateDepartment of Gastroenterology and Hepatology, Kurashiki Central Hospital, Kurashiki, Japan.
Kazuya KitamuraDepartment of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.
Akihiro YamadaDepartment of Internal Medicine, Sakura Medical Center, Toho University, Sakura, Japan.
Akira SonodaDepartment of Gastroenterology, Oita University, Yufu, Japan.
Yu NishidaDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kyouko YoshiokaDepartment of Gastroenterology, Kure Kyosai Hospital, Kure, Japan.
Shinya AshizukaCirculatory and Body Fluid Regulation, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Fumiaki TakahashiDepartment of Internal Medicine, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan.
Toshio ShimokawaDepartment of Medical Data Science, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan.
Taku KobayashiCenter for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Akira AndohDivision of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.
Toshifumi HibiCenter for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Kitasato Institute Hospital · JPFukuoka University · JPShiga University of Medical Science · JPTokyo Medical and Dental University · JPAshikaga Red Cross Hospital · JPGunma Chuo Hospital · JPHirosaki University · JPHiroshima University Hospital · JPKanazawa University Hospital · JPKansai Medical University · JPKawasaki Medical School · JPKeio University · JPKobe University · JPKurashiki Central Hospital · JPKure Kyosai Hospital · JPKyoto University · JPKyushu University · JPNagoya City University · JPNara Medical University · JPOita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmall bowel stricture is one of the most common complications in patients with Crohn's disease (CD). Endoscopic balloon dilatation (EBD) is a minimally invasive treatment intended to avoid surgery; however, whether EBD prevents subsequent surgery remains unclear. We aimed to reveal the factors contributing to surgery in patients with small bowel stricture and the factors associated with subsequent surgery after initial EBD.

methodsData were retrospectively collected from surgically untreated CD patients who developed symptomatic small bowel stricture after 2008 when the use of balloon-assisted enteroscopy and maintenance therapy with anti-tumor necrosis factor (TNF) became available.

resultsA total of 305 cases from 32 tertiary referral centers were enrolled. Cumulative surgery-free survival was 74.0% at 1 year, 54.4% at 5 years, and 44.3% at 10 years. The factors associated with avoiding surgery were non-stricturing, non-penetrating disease at onset, mild severity of symptoms, successful EBD, stricture length < 2 cm, and immunomodulator or anti-TNF added after onset of obstructive symptoms. In 95 cases with successful initial EBD, longer EBD interval was associated with lower risk of surgery. Receiver operating characteristic analysis revealed that an EBD interval of ≤ 446 days predicted subsequent surgery, and the proportion of smokers was significantly high in patients who required frequent dilatation.

conclusionsIn CD patients with symptomatic small bowel stricture, addition of immunomodulator or anti-TNF and smoking cessation may improve the outcome of symptomatic small bowel stricture, by avoiding frequent EBD and subsequent surgery after initial EBD.

Indexed as

Balloon EnteroscopyAdultConstriction, PathologicCrohn DiseaseEndoscopyFemaleHumansImmunologic FactorsIntestinal ObstructionIntestine, SmallMaleRetrospective StudiesSmoking CessationTime FactorsTreatment OutcomeTumor Necrosis Factor InhibitorsImmunologic FactorsTumor Necrosis Factor InhibitorsBalloon enteroscopeInflammatory bowel diseaseStenosis

Identifiers

PMID31989252
OpenAlexW3002771938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.